SCHEDULE 13G: Clark R. Crosnoe and Affiliates Disclose 11.1% Passive Stake in cbdMD, Inc. Following Corporate Actions
Schedule 13G Filing
Clark R. Crosnoe and associated entities have disclosed a combined 11.1% passive beneficial ownership stake in cbdMD, Inc. common shares, following recent corporate actions including a preferred stock conversion and a reverse stock split.
Summary
- Clark R. Crosnoe, along with CRC Investment Fund LP, NM 2018 Trust, and AMC Legacy Trust, collectively reported beneficial ownership of 986,851 common shares of cbdMD, INC., representing 11.1% of the company's outstanding common stock.
- CRC Investment Fund LP holds 823,125 common shares, accounting for 9.2% of the class.
- NM 2018 Trust holds 126,750 common shares, representing 1.4% of the class.
- AMC Legacy Trust holds 36,976 common shares, representing 0.4% of the class.
- Clark R. Crosnoe is the managing member of CRC Investment Fund GP, LLC (general partner of CRC LP) and has investment authority over the trusts, disclaiming beneficial ownership except for his pecuniary interest.
- The reported ownership percentage is based on 8,907,854 outstanding common shares of cbdMD, INC. as of May 6, 2025.
- This outstanding share count reflects the issuance of 65,000,000 common shares upon conversion of the Issuer's 8% Series A Cumulative Convertible Preferred Stock and a subsequent one-for-eight reverse stock split, both effective May 6, 2025.
- The filing explicitly states that the securities were not acquired and are not held for the purpose or effect of changing or influencing the control of cbdMD, INC.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, explicitly stating that the acquisition was not for the purpose of changing or influencing control. It provides no positive or negative performance indicators, thus maintaining a neutral sentiment.
Positives
- The disclosure of a significant passive ownership stake by an investor group may signal confidence in the company's long-term prospects from these investors.
- The clarity regarding the passive nature of the investment (not for control) can reduce uncertainty regarding potential activist interventions.
Risks
- The recent corporate actions, including the conversion of preferred stock and a reverse stock split, indicate significant changes to the company's capital structure, which can introduce volatility or uncertainty for existing shareholders.
- While the filing states no intent to influence control, a large ownership stake always carries the potential for future influence, even if currently disclaimed.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This Schedule 13G filing primarily concerns a change in beneficial ownership structure for cbdMD, INC. and does not provide broader insights into industry trends or competitive landscape. It reflects an investor's position within the company's capital structure.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Ownership Disclosure | The filing certifies that the securities were not acquired and are not held for the purpose or with the effect of changing or influencing the control of the issuer, aligning with passive investment rules. | May 6, 2025 | This statement clarifies the passive nature of the significant ownership stake, indicating no immediate intent for activist intervention or governance changes by the reporting parties. |
Stakeholder Impact
- Shareholders: The disclosure of a significant ownership stake by a passive investor group provides transparency regarding the company's ownership structure. The recent reverse stock split and preferred stock conversion have directly impacted the number of outstanding shares and the per-share value for existing shareholders.
Key Dates
| Date | Description |
|---|---|
| April 4, 2018 | Date of establishment for NM 2018 Trust |
| December 21, 2012 | Date of establishment for AMC Legacy Trust |
| February 21, 2025 | Date as of which 6,262,833 common shares were outstanding, as disclosed in the Issuer's proxy statement |
| February 25, 2025 | Date the Issuer's proxy statement was filed with the SEC |
| May 6, 2025 | Date of event requiring the filing of this statement; effective date of 65,000,000 common share issuance upon preferred stock conversion and one-for-eight reverse stock split |
| May 12, 2025 | Date of execution for the Joint Filing Agreement and the Schedule 13G signatures |
Keywords
cbdMD, Schedule 13G, beneficial ownership, common shares, reverse stock split, preferred stock conversion, Clark R. Crosnoe, institutional investment, SEC filing, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.